Почетна › Рак јетре (хепатоцелуларни карцином) › Њујорк › New York City
Kliničke studije za Рак јетре (хепатоцелуларни карцином) u gradu New York City, NY
27 studija za Рак јетре (хепатоцелуларни карцином) traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Тражи се учесникОпсервациона студија
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- и још 1
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- USA04-0, New York
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Тражи се учесникФаза 1
- Clinical Trial Site, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Тражи се учесникФаза 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center - New York, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 107, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Тражи се учесникФаза 1
- New York Cancer & Blood Specialists, New York
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Тражи се учесникФаза 1
- Columbia University Irving Medical Center, New York
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 255132, New York
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Trial Site, New York
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Тражи се учесникФаза 3
- Research Site, New York
- Research Site, New York
- Research Site, New York
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of ZW251 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #60, New York
- Exelixis Clinical Site #6, New York
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Тражи се учесникФаза 1/2
- Research Facility, New York
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Тражи се учесникФаза 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Тражи се учесникФаза 3
- Mount Sinai Hospital, New York
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Тражи се учесникФаза 4
- Icahn School of Medicine at Mount Sinai, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Тражи се учесникФаза 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Тражи се учесник
- VA NY Harbor Healthcare System, New York, NY, New York
HOPE Against Cancer Recurrence in HCC
Тражи се учесникФаза 4
- Rutgers New Jersey Medical School (New York), New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, New York
The Dragon PLC Trial (DRAGON-PLC)
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Тражи се учесникФаза 1/2
- Memorial Sloan-Kettering Cancer Center, New York
Studije za Рак јетре (хепатоцелуларни карцином) u drugim gradovima
- Houston, TX29 студија
- Los Angeles, CA20 студија
- Dallas, TX19 студија
- Boston, MA18 студија
- Cleveland, OH18 студија
- Philadelphia, PA17 студија
- Chicago, IL17 студија
- Pittsburgh, PA16 студија
- San Francisco, CA15 студија
- Jacksonville, FL14 студија
- St. Louis, MO14 студија
- Orange, CA14 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.